Jane Street Group, LLC Omeros Corp Put Options Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$5.07 - $7.2 $689,520 - $979,200	-136,000 Reduced 86.62%	21,000 $126,000
Q4 2021 Feb 15, 2022	SELL	$5.67 - $8.54 $119,070 - $179,339	-21,000 Reduced 11.8%	157,000 $1.01 Million
Q3 2021 Nov 16, 2021	BUY	$13.4 - $16.3 $160,800 - $195,600	12,000 Added 7.23%	178,000 $2.46 Million
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $1.66 Million - $2.14 Million	112,000 Added 207.41%	166,000 $2.46 Million
Q1 2021 May 18, 2021	SELL	$14.52 - $23.53 $580,800 - $941,200	-40,000 Reduced 42.55%	54,000 $961,000
Q4 2020 Feb 17, 2021	SELL	$10.14 - $15.19 $149,058 - $223,293	-14,700 Reduced 13.52%	94,000 $1.34 Million
Q3 2020 Nov 17, 2020	BUY	$9.57 - $21.32 $919,677 - $2.05 Million	96,100 Added 762.7%	108,700 $1.1 Million
Q1 2020 May 15, 2020	BUY	$9.03 - $19.72 $113,777 - $248,472	12,600 New	12,600 $168,000
Q2 2018 Aug 15, 2018	SELL	$10.79 - $24.44 $235,221 - $532,792	-21,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.0 - $20.16 $53,100 - $118,944	5,900 Added 37.11%	21,800 $244,000
Q4 2017 Feb 15, 2018	BUY	$13.26 - $22.86 $210,834 - $363,474	15,900	15,900 $309,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.